MINK THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.04 USD | -7.14% |
|
+11.83% | -2.80% |
| May. 14 | Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| May. 14 | MiNK Therapeutics, Inc. announced that it has received $5.8 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 38.87M | - | - | - | - | - | |
| 49.18B | - | |||||
| 42.11B | ||||||
| 40.37B | ||||||
| 28.85B | ||||||
| 26.09B |
